BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21372391)

  • 1. Anti-angiogenic activity and intracellular distribution of epigallocatechin-3-gallate analogs.
    Piyaviriyakul S; Shimizu K; Asakawa T; Kan T; Siripong P; Oku N
    Biol Pharm Bull; 2011; 34(3):396-400. PubMed ID: 21372391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis.
    Yamakawa S; Asai T; Uchida T; Matsukawa M; Akizawa T; Oku N
    Cancer Lett; 2004 Jul; 210(1):47-55. PubMed ID: 15172120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells.
    Tang FY; Chiang EP; Shih CJ
    J Nutr Biochem; 2007 Jun; 18(6):391-9. PubMed ID: 17049832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigallocatechin-3-gallate inhibits tumor angiogenesis: involvement of endoglin/Smad1 signaling in human umbilical vein endothelium cells.
    Chen CY; Lin YJ; Wang CCN; Lan YH; Lan SJ; Sheu MJ
    Biomed Pharmacother; 2019 Dec; 120():109491. PubMed ID: 31586903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate plays more predominant roles than caffeine for inducing actin-crosslinking, ubiquitin/proteasome activity and glycolysis, and suppressing angiogenesis features of human endothelial cells.
    Gallemit PEM; Yoodee S; Malaitad T; Thongboonkerd V
    Biomed Pharmacother; 2021 Sep; 141():111837. PubMed ID: 34175818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex.
    Rodriguez SK; Guo W; Liu L; Band MA; Paulson EK; Meydani M
    Int J Cancer; 2006 Apr; 118(7):1635-44. PubMed ID: 16217757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation induced-tubulogenesis in endothelial cells is antagonized by the antiangiogenic properties of green tea polyphenol (-) epigallocatechin-3-gallate.
    Annabi B; Lee YT; Martel C; Pilorget A; Bahary JP; Béliveau R
    Cancer Biol Ther; 2003; 2(6):642-9. PubMed ID: 14688468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of fibroblast growth factors by green tea.
    Sartippour MR; Heber D; Zhang L; Beatty P; Elashoff D; Elashoff R; Go VL; Brooks MN
    Int J Oncol; 2002 Sep; 21(3):487-91. PubMed ID: 12168090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells.
    Singh AK; Seth P; Anthony P; Husain MM; Madhavan S; Mukhtar H; Maheshwari RK
    Arch Biochem Biophys; 2002 May; 401(1):29-37. PubMed ID: 12054484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real Time Monitoring of Inhibition of Adipogenesis and Angiogenesis by (-)-Epigallocatechin-3-Gallate in 3T3-L1 Adipocytes and Human Umbilical Vein Endothelial Cells.
    Tang W; Song H; Cai W; Shen X
    Nutrients; 2015 Oct; 7(10):8871-86. PubMed ID: 26516907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro screening for angiostatic potential of herbal chemicals.
    Cao L; Liu H; Lam DS; Yam GH; Pang CP
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6658-64. PubMed ID: 20671276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy and endothelial cells--(green) tea for two?
    Vuori K
    Cancer Biol Ther; 2003; 2(6):650-1. PubMed ID: 14688469
    [No Abstract]   [Full Text] [Related]  

  • 15. Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis.
    Siddiqui IA; Malik A; Adhami VM; Asim M; Hafeez BB; Sarfaraz S; Mukhtar H
    Oncogene; 2008 Mar; 27(14):2055-63. PubMed ID: 17998943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (-)-Epigallocatechin gallate suppresses proliferation of vascular smooth muscle cells induced by high glucose by inhibition of PKC and ERK1/2 signalings.
    Yang J; Han Y; Sun H; Chen C; He D; Guo J; Yu C; Jiang B; Zhou L; Zeng C
    J Agric Food Chem; 2011 Nov; 59(21):11483-90. PubMed ID: 21973165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells.
    Ohga N; Hida K; Hida Y; Muraki C; Tsuchiya K; Matsuda K; Ohiro Y; Totsuka Y; Shindoh M
    Cancer Sci; 2009 Oct; 100(10):1963-70. PubMed ID: 19650861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    Jung YD; Ellis LM
    Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid type 1 is vital for (-)-epigallocatechin-3-gallate mediated activation of endothelial nitric oxide synthase.
    Guo BC; Wei J; Su KH; Chiang AN; Zhao JF; Chen HY; Shyue SK; Lee TS
    Mol Nutr Food Res; 2015 Apr; 59(4):646-57. PubMed ID: 25581901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
    Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
    Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.